Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI)
Drug-induced liver injury (DILI) is a major safety issue during drug development, as well as the most common cause for the withdrawal of drugs from the pharmaceutical market. The identification of DILI biomarkers is a labor-intensive area. Conventional biomarkers are not specific and often only appe...
Main Author: | |
---|---|
Other Authors: | , , , |
Format: | article |
Language: | eng |
Published: |
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10284/10036 |
Country: | Portugal |
Oai: | oai:bdigital.ufp.pt:10284/10036 |